Precise nanodrug delivery systems with cell-specific targeting for ALI/ARDS treatment

Area of Science:

• Nanomedicine
• Biomedical Engineering
• Pulmonary Medicine

Background:

• Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are critical clinical conditions lacking effective treatments.
• Precision medicine necessitates advanced drug delivery systems for targeted therapies.
• Nanomedicine research is exploring Nanodrug Delivery Systems (NDDSs) for cell-specific targeting.

Purpose of the Study:

• To review Nanodrug Delivery Systems (NDDSs) targeting specific cells relevant to ALI/ARDS pathology.
• To provide insights into designing NDDSs for precise drug delivery in ALI/ARDS.
• To explore novel targeted treatment strategies for ALI/ARDS.

Main Methods:

• Review of existing literature on NDDSs for ALI/ARDS.
• Analysis of pathological microenvironment characteristics of ALI/ARDS.
• Identification of target cells including vascular endothelial cells, neutrophils, alveolar macrophages, and alveolar epithelial cells.

Main Results:

• NDDSs offer a strategy to alter drug distribution, concentrating therapeutic agents at target sites.
• Targeted delivery enhances drug efficacy and minimizes adverse reactions in ALI/ARDS.
• Specific cell targeting in ALI/ARDS can lead to more accurate nano-targeted treatments.

Conclusions:

• Designing NDDSs based on ALI/ARDS microenvironment characteristics is crucial for effective treatment.
• Targeting specific cells like vascular endothelial cells, neutrophils, and alveolar cells shows promise for ALI/ARDS therapy.
• This review provides a reference for developing accurate NDDSs and novel targeted treatments for ALI/ARDS.